
Our Innovative Mastitis Vaccine: Mastidoll-3 Ready to Serve Breeders!
We believe that Mastidoll-3, our innovative Mastitis vaccine R&D activities of which took 12
Dollvet was established in Şanlıurfa Organized Industrial Zone within a 36.000-sqm campus and now carries out its commercial activity with 26 veterinary vaccine licenses and 3 test kit licenses.
Dollvet has the ability to produce its biotechnology products at world standards in its GMP-certificated production campus.
More than half of over 150 employees working within Dollvet consists of experts.
Dollvet has developed many qualified products with its R&D activities mostly conducted with its equities since its establishment.
in 36.000-sqm Campus!
We believe that Mastidoll-3, our innovative Mastitis vaccine R&D activities of which took 12
VIV MEA 2020 will meet its visitors with more than 400 companies from Europe,